← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2013Last known activity
Mar 2, 2021
Timeline
2010s
- Jan 1, 2013
Public Health England— Founded
Drugs by trial phase (38 distinct, 39 trials)
Phase 4 (21 own, 0 via acquisition)
- diphtheria, tetanus and whole cell pertussis vaccine
- flucloxacillin
- fluarix
- menitorix
- menjugate
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- pneumococcal 13-valent conjugate vaccine
- live attenuated influenza virus vaccine
- inactivated influenza vaccine
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- 10-valent Pneumococcal Conjugate Vaccine
- azithromycin
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- hpv 16/18 vaccine
- clindamycin
- +6 more
Phase 3 (5 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Asthma
- Cellulitis
- Communicable Diseases
- Diphtheria
- Egg Hypersensitivity
- Hemorrhagic Fever, Ebola
- Hepatitis
- Hepatitis B
- Hypersensitivity
- Infections
- Influenza, Human
- Meningitis
- Meningitis, Meningococcal
- Meningococcal Infections
- Papillomavirus Infections
- Pneumococcal Infections
- Pneumonia
- Premature Birth
- Staphylococcal Infections
- Virus Diseases
- Whooping Cough
Recent trials (50)
- NCT04665791CollaboratorN/AMar 2, 2021
- NCT04152486CollaboratorPhase 3Nov 14, 2019
- NCT03832049CollaboratorPhase 3Jul 31, 2019
- NCT03746665CollaboratorPhase 3Dec 19, 2018
- NCT03735147CollaboratorPhase 4Oct 23, 2018
- NCT03104790Overall official - principal investigatorPhase 4Sep 30, 2017
- NCT03104790Lead sponsorPhase 4Sep 30, 2017
- NCT02918708Overall official - principal investigatorPhase 4Jul 1, 2017
- NCT02918708Lead sponsorPhase 4Jul 1, 2017
- NCT03751514CollaboratorN/AMay 22, 2017
- NCT03125616CollaboratorPhase 4May 15, 2017
- NCT02972957CollaboratorPhase 4Jan 1, 2017
- NCT02866942CollaboratorPhase 4Oct 1, 2016
- NCT02549365CollaboratorPhase 4Oct 1, 2015
- NCT02482636CollaboratorPhase 2Aug 1, 2015
Details
- Founded
- London, GB Jan 1, 2013
- Last known activity
- Mar 2, 2021